Oral vaccination with feed-based live attenuated vaccine protects large yellow croaker against Pseudomonas plecoglossicida infection

Abstract

Pseudomonas plecoglossicida is a facultative Gram-negative bacteria that causes ‘visceral granulomas disease’ (VGD) in large yellow croaker (LYC; Larimichthys crocea) and several other fish species leading to high economic losses. Currently, there are no commercial vaccines against VGD. Thus, we evaluated the efficacy of a live attenuated vaccine (LAV) made by our laboratory in LYC administered orally in alginate-coated LAV-loaded feeds. To evaluate the tolerance of the LAV in the acidic environment of the stomach, we treated the alginate-coated LAV with a simulated gastric juice without pepsin. There was a 10-fold decrease in the number of viable LAV cells after treatment with the simulated gastric juice (pH 2.0). Despite so, we found a significant increase in LAV cells in the liver and hindgut within 4 h post first feeding of oral vaccine (hpff), which increased to high levels by 24 hpff indicating that LAV cells that survived the stomach acidic environment reached the hindgut for adsorption. Although there was a transient change in the composition of the gut microbiota at 24 hpff, analysis using the Shannon and β-diversity indices showed a similarity in the bacterial composition found before and after vaccination indicating that the LAV had no long-term adverse effect on the gut microbiota. Systemic and mucosal humoral responses were characterized by high serum antibody levels and upregulation of the pig and sign while activation of cell-mediated immunity was characterized by upregulation of MHC-Iα, MHC-IIβ, Prf1 and IFNγ genes. The overall protection in vaccinated LYC was estimated at relative percent survival (RPS) of 60%. Altogether, this study has shown that LAVs can be used as oral vaccines to confer protective immunity without impacting adverse effects on the fish microbiota.